Understanding and harnessing the graft-versus-leukaemia effect

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• The graft-versus-leukaemia (GVL) effect is crucial for curing hematological malignancies via allogeneic stem cell transplantation.
• Donor natural killer cells and T lymphocytes mediate GVL through distinct recognition mechanisms against recipient malignant cells.

Purpose of the Study:

• To explore strategies for optimizing the GVL effect in stem cell transplantation.
• To identify factors influencing GVL and discuss future directions for enhancing its efficacy against resistant leukemias.

Main Methods:

• Review of clinical studies and existing literature on stem cell transplantation and GVL.
• Analysis of factors such as transplant preparation, donor selection, stem cell source, and post-transplant management.

Main Results:

• The cytokine milieu post-transplantation supports early GVL, but graft-versus-host disease (GVHD) prevention limits its full potential.
• Clinical studies have identified key components that can be manipulated to optimize GVL.

Conclusions:

• Further research is needed to selectively deplete unwanted alloreactivity while preserving GVL.
• Vaccines and adoptive transfer of leukemia-specific lymphocytes are potential future strategies to enhance GVL for resistant leukemias.